Soundbite Medical Solutions Inc. specializes in innovative interventional technologies aimed at addressing vascular calcification, a significant challenge in treating advanced atherosclerotic disease. Their proprietary method utilizes shock waves to perform intravascular lithotripsy (IVL), effectively targeting calcified lesions in patients with coronary and peripheral artery disease. The SoundBite System employs an array of waveguides to generate and deliver these shock waves in a controlled manner, allowing for the safe treatment of chronic total occlusions (CTOs) and other calcific blockages. This technology not only enhances the efficacy of treatment but also minimizes risks associated with traditional methods, such as perforation and embolization.

The SoundBite XS Crossing System represents a significant advancement in the field, being the first IVL wire-based technology designed specifically for navigating chronic total occlusions. This system facilitates the intraluminal placement of guidewires and treatment devices beyond these challenging blockages, thereby improving procedural success rates. Soundbite Medical is committed to expanding its product portfolio to address unmet clinical needs across various vascular beds, with ongoing clinical trials and studies aimed at validating the performance of their technologies. Their focus on safety, simplicity, and efficacy positions them as a leader in transforming the standard of care for patients suffering from calcific occlusive cardiovascular disease.

Canada

SoundBite is a medical devices start-up, Montreal and Sherbrooke-based, developing and commercializing proprietary shockwave device and generator technology delivered within the cardiovascular system to treat chronic total occlusions (CTO's).
The company will target CTO's in patients with peripheral artery disease (PAD) and coronary artery disease (CAD), disease states that affect over 12 million and 8 million Americans, respectively.

Soundbite Medical Solutions Inc.

Company Details